Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing
Isabel Prager, Clarissa Liesche, Hanna van Ooijen, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 9, pp. 2113-2127
Open Access | Times Cited: 292

Showing 1-25 of 292 citing articles:

NK cells for cancer immunotherapy
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 973
Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers, Jeffrey S. Miller
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 2, pp. 85-100
Open Access | Times Cited: 931
The cancer–natural killer cell immunity cycle
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 448
Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma
Hamid Maadi, Mohammad Hasan Soheilifar, Wonshik Choi, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3540-3540
Open Access | Times Cited: 121
Cell death, therapeutics, and the immune response in cancer
Kay Hänggi, Brian Ruffell
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 381-396
Open Access | Times Cited: 110
The NK-92 cell line—30 years later: its impact on natural killer cell research and treatment of cancer
Hans Klingemann
Cytotherapy (2023) Vol. 25, Iss. 5, pp. 451-457
Open Access | Times Cited: 67
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
Benjamin Ruf, Tim F. Greten, Firouzeh Korangy
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 351-371
Closed Access | Times Cited: 52
Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches
Yaxian Wang, Xinyang Zhong, Xuefeng He, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 43
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 38
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Beibei Zhang, Mengzhe Yang, Weimin Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer
Aristo Vojdani, Sadi Köksoy, Elroy Vojdani, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 230-230
Open Access | Times Cited: 25
Natural Killer cells at the frontline in the fight against cancer
Loïs Coënon, Mannon Geindreau, François Ghiringhelli, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 18
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Ana Santiso, Ákos Heinemann, Julia Kargl
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 388-413
Open Access | Times Cited: 17
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Shan Liu, Xingda Zhang, Wenzheng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells
Michael Morgan, Hildegard Büning, Martin G. Sauer, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 124
A Functional Chemiluminescent Probe for in Vivo Imaging of Natural Killer Cell Activity Against Tumours
Jamie I. Scott, Sara Gutkin, Ori Green, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 11, pp. 5699-5703
Open Access | Times Cited: 107
Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine
Silvia Capellino, Maren Claus, Carsten Watzl
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 7, pp. 705-711
Open Access | Times Cited: 95
High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
Stephan Müller, Tobias Bexte, Veronika Gebel, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 93
Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective
Egle Ramelyte, Aizhan Tastanova, Zsolt Balázs, et al.
Cancer Cell (2021) Vol. 39, Iss. 3, pp. 394-406.e4
Open Access | Times Cited: 93
NK Cells in the Tumor Microenvironment
Camille Guillerey
Advances in experimental medicine and biology (2020), pp. 69-90
Closed Access | Times Cited: 86
Nano-herb medicine and PDT induced synergistic immunotherapy for colon cancer treatment
Xiaoli Wu, Han Yang, Xingmeng Chen, et al.
Biomaterials (2021) Vol. 269, pp. 120654-120654
Closed Access | Times Cited: 84
Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer
Ina Bähr, Julia Spielmann, Dagmar Quandt, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 82
The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting
Yang Li, Gen Li, Jian Zhang, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 69
The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic
Nandeeta Samad, Temitayo Eniola Sodunke, Abdullahi Rabiu Abubakar, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 527-550
Open Access | Times Cited: 63
All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity
Ariel Ramírez-Labrada, Cecilia Pesini, Llipsy Santiago, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top